Bipolar Disorder Depressive Episode clinical trials

Explore recruiting bipolar disorder depressive episode clinical trials.

Recruiting bipolar disorder depressive episode studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Bipolar Disorder Depressive Episode trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Esketamine nasal spray (Spravato) for the treatment of therapy-resistant bipolar depression. An open-label pilot trial.

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Bipolar Disorder Depressive Episode trials by city

Bipolar Disorder Depressive Episode clinical trials

Recruiting bipolar disorder depressive episode studies right now

Efficacy and Safety of Magnesium Vitamin B6 in First Episode Bipolar Disorder

Closed-Loop Deep Brain Stimulation for Treatment-Resistant Bipolar Depression

A Study of Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Bipolar Depression

Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.

Validation of a Composite Medical Device Using a Blood Biomarker-based Algorithm and MDQ for the Diagnosis of Bipolar Disorder

A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.

Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

ALTO-100 in Bipolar Disorder With Depression (BD-D)

Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder

BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study

Evaluation of the Efficacy, Safety, and Tolerability of Lacosamide in Major Depressive Episodes of Bipolar Disorder Types I and II.

A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)

Also recruiting in Europe

Esketamine nasal spray (Spravato) for the treatment of therapy-resistant bipolar depression. An open-label pilot trial.

Bipolar Disorder Depressive Episode trials by city

Other conditions